Abstract
Evaluation of suitability for glucagon-like peptide-2 treatment in a large population of home parenteral support patients
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have